382 related articles for article (PubMed ID: 32135530)
1. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
2. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
3. Accounting for prompt gamma emission and detection for range verification in proton therapy treatment planning.
Tian L; Huang Z; Janssens G; Landry G; Dedes G; Kamp F; Belka C; Pinto M; Parodi K
Phys Med Biol; 2021 Feb; 66(5):055005. PubMed ID: 33171445
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
5. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
6. An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity.
Bueno M; Paganetti H; Duch MA; Schuemann J
Med Phys; 2013 Aug; 40(8):081704. PubMed ID: 23927301
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo evaluation of tissue inhomogeneity effects in the treatment of the head and neck.
Wang L; Yorke E; Chui CS
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1339-49. PubMed ID: 11483347
[TBL] [Abstract][Full Text] [Related]
8. Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification.
Polf JC; Avery S; Mackin DS; Beddar S
Phys Med Biol; 2015 Sep; 60(18):7085-99. PubMed ID: 26317610
[TBL] [Abstract][Full Text] [Related]
9. Correlations between the shifts in prompt gamma emission profiles and the changes in daily target coverage during simulated pencil beam scanning proton therapy.
Lens E; Jagt TZ; Hoogeman MS; Schaart DR
Phys Med Biol; 2019 Apr; 64(8):085009. PubMed ID: 30921771
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.
Moteabbed M; España S; Paganetti H
Phys Med Biol; 2011 Feb; 56(4):1063-82. PubMed ID: 21263174
[TBL] [Abstract][Full Text] [Related]
11. Fast MCsquare-Based Independent Dose Verification Platform for Pencil Beam Scanning Proton Therapy.
Liu C; Ho MW; Park J; Hsi WC; Liang X; Li Z; Song Y; Feng H; Zhang Y
Technol Cancer Res Treat; 2021; 20():15330338211033076. PubMed ID: 34338058
[TBL] [Abstract][Full Text] [Related]
12. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
[TBL] [Abstract][Full Text] [Related]
13. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.
Bazalova-Carter M; Qu B; Palma B; Hårdemark B; Hynning E; Jensen C; Maxim PG; Loo BW
Med Phys; 2015 May; 42(5):2615-25. PubMed ID: 25979053
[TBL] [Abstract][Full Text] [Related]
14. Shortening delivery times for intensity-modulated proton therapy by reducing the number of proton spots: an experimental verification.
van de Water S; Belosi MF; Albertini F; Winterhalter C; Weber DC; Lomax AJ
Phys Med Biol; 2020 May; 65(9):095008. PubMed ID: 32155594
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo proton dose calculations using a radiotherapy specific dual-energy CT scanner for tissue segmentation and range assessment.
Almeida IP; Schyns LEJR; Vaniqui A; van der Heyden B; Dedes G; Resch AF; Kamp F; Zindler JD; Parodi K; Landry G; Verhaegen F
Phys Med Biol; 2018 May; 63(11):115008. PubMed ID: 29616662
[TBL] [Abstract][Full Text] [Related]
16. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
[TBL] [Abstract][Full Text] [Related]
18. Range shift verification in spot scanning proton therapy using gamma electron vertex imaging.
Kim SH; Jeong JH; Ku Y; Lee SB; Shin D; Lim YK; Kim H; Kim CH
Med Phys; 2024 Mar; 51(3):1985-1996. PubMed ID: 37722712
[TBL] [Abstract][Full Text] [Related]
19. The use of non-standard CT conversion ramps for Monte Carlo verification of 6 MV prostate IMRT plans.
Zarza-Moreno M; Cardoso I; Teixeira N; Jesus AP; Mora G
Phys Med; 2013 Jun; 29(4):357-67. PubMed ID: 22677401
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
